Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in KYMR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.3M | $1.42B | +5.5% | 15.013% | 0.06% |
| 2 | BAKER BROS. ADVISORS LP | 8.7M | $992.7M | 0.0% | 10.525% | 4.97% |
| 3 | Avoro Capital Advisors LLC | 7.5M | $857.1M | 0.0% | 9.087% | 7.70% |
| 4 | BlackRock, Inc. | 5.5M | $635.1M | +9.4% | 6.733% | 0.01% |
| 5 | BVF INC/IL | 3.9M | $444.0M | -29.6% | 4.707% | 11.35% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 3.7M | $421.4M | -5.5% | 4.468% | 0.07% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.0M | $343.1M | +4.1% | 3.638% | 0.02% |
| 8 | Siren, L.L.C. | 2.9M | $336.7M | -7.9% | 3.569% | 6.81% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $336.3M | +1.8% | 3.565% | 0.01% |
| 10 | Atlas Venture Life Science Advisors, LLC | 2.8M | $326.5M | -37.8% | 3.462% | 37.05% |
| 11 | STATE STREET CORP | 2.7M | $313.9M | +14.5% | 3.328% | 0.00% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $208.3M | +10.4% | 2.208% | 0.01% |
| 13 | Capital Research Global Investors | 1.4M | $159.3M | -17.0% | 1.689% | 0.02% |
| 14 | GOLDMAN SACHS GROUP INC | 1.2M | $136.2M | +33.7% | 1.443% | 0.01% |
| 15 | UBS Group AG | 1.0M | $115.6M | -1.6% | 1.225% | 0.01% |
| 16 | DRIEHAUS CAPITAL MANAGEMENT LLC | 919K | $105.4M | -11.9% | 1.117% | 0.61% |
| 17 | Merck & Co., Inc. | 772K | $88.5M | 0.0% | 0.939% | 16.82% |
| 18 | NORGES BANK | 757K | $86.8M | — | 0.921% | 0.01% |
| 19 | FEDERATED HERMES, INC. | 749K | $85.9M | +39.6% | 0.911% | 0.12% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 745K | $85.4M | +25.7% | 0.906% | 0.02% |
| 21 | FRONTIER CAPITAL MANAGEMENT CO LLC | 741K | $85.0M | -2.5% | 0.901% | 0.79% |
| 22 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 737K | $84.5M | -15.9% | 0.896% | 0.02% |
| 23 | ALLIANCEBERNSTEIN L.P. | 982K | $81.8M | +10.5% | 1.193% | 0.03% |
| 24 | Holocene Advisors, LP | 637K | $73.0M | -23.9% | 0.774% | 0.16% |
| 25 | NORTHERN TRUST CORP | 582K | $66.7M | +17.7% | 0.707% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KYMR — a direct measure of their conviction.
Filings activity in KYMR during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new KYMR position in Q2 2026
Institutions that fully closed their KYMR position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 284 | +9.2% | 118.86% | +0.66 pp | $9.63B | +36% |
| Q1 2026 | 260 | +2.8% | 118.20% | +7.29 pp | $7.06B | +9.2% |
| Q4 2025 | 253 | +20% | 110.91% | 2.81 pp | $6.47B | +52% |
| Q3 2025 | 210 | +0.5% | 113.72% | +1.21 pp | $4.26B | +36% |
| Q2 2025 | 209 | +22% | 112.51% | +0.00 pp | $3.12B | +73% |
| Q1 2025 | 171 | 5.0% | 112.51% | +1.97 pp | $1.80B | 30% |
| Q4 2024 | 180 | +2.9% | 110.54% | +3.29 pp | $2.58B | 12% |
| Q3 2024 | 175 | — | 107.25% | — | $2.93B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying KYMR stock.
Based on Q2 2026 13F filings, institutional ownership of Kymera Therapeutics, Inc. stands at 118.9%, held across 284 reporting institutions.
FMR LLC is the largest reported institutional holder of KYMR, with approximately 12,349,256 shares worth $1.42B as of Q2 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of KYMR.
Our composite Smart Money Score for KYMR is 48 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
48 institutions opened new positions in KYMR during Q2 2026, while 25 fully exited. 207 added to existing positions and 23 trimmed.
KYMR institutional ownership rose by 0.66 percentage points quarter-over-quarter, with a net change of +24 holders.
The top 10 institutions account for 63.4% of all reported 13F value in KYMR, and the top 25 account for 81.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Kymera Therapeutics, Inc. (KYMR) Institutional Ownership